Neuphoria Therapeutics Inc (NEUP) stock news · rev $1.2M
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
This NEUP news page leads with what Neuphoria Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for NEUP yet. We will not pad this page with generic market recap.
Latest reported NEUP revenue for 2026-06-30 was $1.2M. Net income was -$13.5M. Revenue was down 92.5% from 2025-06-30 to 2026-06-30. NEUP currently screens at market cap $23.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the NEUP stock page; for the tape open the quote page.
NEUP stock news FAQ
What are NEUP's latest revenue and net income?
Latest cached Neuphoria Therapeutics Inc (NEUP) revenue for Jun 30, 2026 was $1.2M. Net income was -$13.5M. Statements: https://lician.com/financials/neup
How did NEUP revenue change from the prior cached period?
Cached Neuphoria Therapeutics Inc (NEUP) revenue was down 92.5% from $15.6M (Jun 30, 2025) to $1.2M (Jun 30, 2026). Statements: https://lician.com/financials/neup
What is NEUP's market cap?
Neuphoria Therapeutics Inc (NEUP) market cap is $23.6M on the latest cached fundamentals snapshot.
What kind of company is NEUP?
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
Where is NEUP stock news listed?
Cached stock news for Neuphoria Therapeutics Inc (NEUP) is listed at https://lician.com/news/neup. Filings: https://lician.com/sec/neup
Not investment advice.